Major Issues Regarding Estrogen Replacement Therapy in Postmenopausal Women
Author:
- John P. BilezikianJBJohn P. Bilezikian
- 1 August 1994
- journal article
- Published by SAGE Publications in Journal of Women's Health
- Vol. 3 (4) , 273-282
Abstract
No abstract availableThis publication has 42 references indexed in Scilit:
- Estrogen status and heredity are major determinants of premenopausal bone mass.Journal of Clinical Investigation, 1992
- Clinical Use of Bone DensitometryNew England Journal of Medicine, 1991
- The Risk of Breast Cancer after Estrogen and Estrogen–Progestin ReplacementNew England Journal of Medicine, 1989
- Postmenopausal use of estrogen and occlusion of coronary arteriesAmerican Heart Journal, 1988
- The role of oestrogens and progestagens in the epidemiology and prevention of breast cancerEuropean Journal of Cancer and Clinical Oncology, 1988
- Hip Fracture and the Use of Estrogens in Postmenopausal WomenNew England Journal of Medicine, 1987
- Regional and total skeletal measurements in the early postmenopause.Journal of Clinical Investigation, 1987
- Postmenopausal Estrogen Use, Cigarette Smoking, and Cardiovascular Morbidity in Women over 50New England Journal of Medicine, 1985
- BONE MASS IN POSTMENOPAUSAL WOMEN AFTER WITHDRAWAL OF OESTROGEN/GESTAGEN REPLACEMENT THERAPYThe Lancet, 1981
- BONE RESPONSE TO TERMINATION OF ŒSTROGEN TREATMENTThe Lancet, 1978